COVID-19 and HIV: Webinar series

HIV prevention: Revolution through innovation

The International AIDS Society (IAS) is organizing a series of webinars on the topic of COVID-19 and HIV to discuss the pandemic and its impact on people living with HIV. Through these webinar sessions, the IAS would like to provide an opportunity for discussion around the latest science, in addition to sharing learning and best practices in relation to COVID-19 and HIV between countries at different stages of the pandemic, especially in lower- and middle-income countries.

The webinars are recommended to HIV professionals, government representatives working in the field of HIV, public health specialists, programme managers, service providers, civil society representatives and members of organizations supporting key and vulnerable populations.

COVID-19 and HIV: Adapting community-based HIV services during a pandemic

This webinar was held on 28 May 2020.

  • Mitigating the impact of COVID-19 for key populations – Dr Chris Akolo, Technical Director of LINKAGES Project, Family Health International 360 – USA

    Presentation

  • Adapting sex worker services during the COVID-19 pandemic – Surang Janyam, Founder and Director of Service Workers IN Group (SWING) Foundation – Thailand

    Presentation

  • Maintaining harm reduction services during the COVID-19 pandemic – Anton Basenko, Country Focal Point: PITCH, Alliance for Public Health – Ukraine

    Presentation

  • Ensuring access to HIV treatment in lockdown – Prof Mehdi Karkouri, President of Association de Lutte Contre le SIDA and Board Member of Coalition Plus – Morocco

    Presentation

  • Adapting community-based HIV services during a pandemic – Mather Mawodzeke, Head of Programmes, Africaid Zvandiri – Zimbabwe

    Presentation

  • Sexual Reproductive Health & Rights during the COVID-19 pandemic – Nisha Jagdish, Director of Gender and Rights Program, Family Planning Association – India

    Presentation

Webinar recording

COVID-19: Building on the HIV response to introduce innovation in a pandemic

This webinar was held on 14 May 2020.

  • Innovation in a pandemic: 40 years of HIV to the rescue? – Prof Sharon Lewin, IAS Governing Council representative, Asia and the Pacific Islands, and Director, Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Australia Presentation

    Presentation

  • Oral testimonies

    Philippe Jacon, Senior Vice President Global Access, Cepheid, France

    Dr Jim Rooney, Vice President of Clinical Research, Gilead, USA

    Dr Mookho Malahleha, Co-principal Investigator, HVTN 702, and Deputy Director, Setshaba Research Centre, South Africa

    Maureen Luba Milambe, Africa Region Advocacy Advisor, AIDS Vaccine Advocacy Coalition (AVAC), Enterprise Advisory Group Member, VARG, Malawi

Webinar recording

Test, test, test: COVID-19 and HIV testing updates

This webinar was held on 30 April 2020.

  • WHO updates on COVID-19 testing – Dr Lara Vojnov, Diagnostics Advisor, HIV and Hepatitis Department, WHO

    Presentation

  • Strategies for HIV testing and initiation of treatment during the COVID-19 pandemic – Dr Rachel Baggaley, Coordinator of HIV testing and prevention, WHO

    Presentation

  • COVID-19 tests: Innovations available – Dr Cassandra Kelly-Cirino, Director, Emerging Threats, FIND

     

  • Lessons learned on testing from South Korea – Dr Jerome Kim, Director General, International Vaccine Institute, Seoul

    Presentation

  • Lessons learned on testing from Singapore – Dr Benson Yeo Koon Wee, Consultant and Deputy Head, DSC Clinic

    Presentation

Webinar recording

COVID-19 and HIV: Lessons learned from healthcare workers around the world

These webinars, brought to you by the IAS Educational Fund, were held on the 21 April 2020.

SESSION 1:

Lessons learned from:

  • China – Dr Ke Liang, Associate Chief Physician, Infectious Diseases Department, Zhongnan Hospital of Wuhan University

    Presentation

  • Italy – Dr Cristina Mussini, IAS Governing Council Member and Professor of Infectious Diseases at the University of Modena and Reggio Emilia

    Presentation

  • Kenya – Dr Catherine Ngugi, Head, Division of National AIDS & STI Control Program, Ministry of Health

    Presentation

  • Lebanon – Dr Ghassan Abu-Sittah, Head of Plastic and Reconstructive Surgery and co-Director of the Conflict Medicine Program, Global Health Institute, American University of Beirut

  • South Africa – Prof Graeme Meintjes, Infectious Diseases Physician, University of Cape

    Presentation

  • South Africa – Dr Tracy Flowers, Welcome Service Manager, MSF, Khayelitsha

    Presentation

  • United Kingdom – Dr Marta Boffito, Consultant Physician and HIV Service Director Chelsea and Westminster Hospital, London

    Presentation

  • Moderator: Dr Shannon Hader, Assistant Secretary General, Deputy Executive Director, UNAIDS

SESSION 2:

Lessons learned from:

  • Brazil - Dr Estevão Portela, Deputy Director of Clinical Services, Evandro Chagas National Institute of Infectious Diseases, Fiocruz

    Presentation

  • Dominican Republic - Dr Robert Paulino-Ramírez, Director, Institute of Tropical Medicine & Global Health, Universidad Iberoamericana

    Presentation

  • Ecuador - Dr Amira Herdoiza, Executive Director, NGO Kimirina

    Presentation

  • Mexico - Dr Brenda Crabtree, Staff Physician, Infectious Diseases Department, National Institute of Health Sciences and Nutrition, Salvador Zubirán and Assistant Professor of the HIV Programme at National Autonomous University of Mexico

    Presentation

  • USA - Prof Monica Gandhi, Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco

    Presentation

  • Moderator: Dr Shannon Hader, Assistant Secretary General, Deputy Executive Director, UNAIDS

Webinar recordings

(21 April 2020 - Session 1)

(22 April 2020 - Session 2)

COVID-19 and HIV: What you need to know

This webinar, brought to you by the IAS Educational Fund, was held on the 3 April 2020.

  • Latest WHO updates and guidance on COVID-19 and HIV
    Dr Meg Doherty, Director of Global HIV, Hepatitis and STI Programme, WHO

    Presentation

    Dr Doherty emphasized that these are “unprecedented times” and there is a need for a nimble and evidence-based response. To date, approximately 14 cases of co-infection of HIV and SARS-CoV-2 (the virus that causes COVID-19) have been documented, including four in China and 10 others. Given the small number, currently, there is “no evidence that the risk of infection or complications of COVID-19 is different among people living with HIV who are clinically and immunologically stable on antiretroviral therapy [ART] when compared with the general population”.

    Dr Doherty highlighted the importance of people living with HIV continuing to take their antiretrovirals and having a supply of three to six months of treatment on hand. She explained that WHO is shifting its language from “social distancing” to “physical distancing”. She also underscored the importance of people living with HIV staying connected with their communities and addressing stress and anxiety with friends, families and healthcare providers.

    Dr Doherty did point to some concerns about the supply chain as a result of the lockdown in India where the majority of the world’s antiretrovirals are manufactured. WHO and partners are monitoring the situation closely.

    She emphasized that masks are a limited commodity that must be used where they’re needed most – critically, for healthcare workers. The right type of mask should be used for the right situation, including by those who are symptomatic. She said WHO is updating guidance as new information and data become available.

    Everyone is encouraged to regularly check the WHO website for updates for guidance, information and recommendations. Dr Doherty highlighted the recently published documentation on what are essential health services and the “Solidarity” clinical trial, a multi-country randomized trial to compare the relative effectiveness of four different treatment options for COVID-19.

  • Global health systems preparedness
    Dr Anton Pozniak, President IAS, Consultant Physician and Director TB service, Chelsea and Westminster Hospital London, and Professor (Clinical Research) LSHTM, UK

    Presentation

    Dr Pozniak underscored the interconnectivity of the world in 2020 and how the broader determinants of health, such as economics, migration and climate change, are integral to consider within pandemic prevention. He raised the potential impact of the COVID-19 pandemic on mental health, noting that a pandemic often results in heightened social tension, discrimination and fear-induced behaviour.

  • Frontline lessons learned and measures implemented for people living with HIV
    Dr Olivier Nawej, Senior Resident, HIV / AIDS consultations, Geneva University Hospitals (HUG)

    Presentation

    Dr Tshikung shared insights from people living with HIV in Hubei, China, and how these are shaping the Geneva healthcare response to support people living with HIV. The HIV Unit in Geneva has prepared for risks related to anxiety among people living with HIV, such as loss to follow up and treatment interruption. The unit has also determined how to protect people who are vulnerable and how to continue providing HIV testing and post-exposure prophylaxis during this time. Actions include increasing telemedicine and maintenance of a hotline, postponing routine follow up for vulnerable people and routine HIV and STI testing for asymptomatic individuals without risk exposure, and supporting home delivery of medication.

  • Moderator:
    Dr Lucy Stackpool-Moore, Director, HIV Programmes and Advocacy, IAS

Webinar recording

(3 April 2020)